Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome.

The Journal of clinical endocrinology and metabolism - 1 Feb 2016

Tosi Flavia, Fiers Tom, Kaufman Jean-Marc, Dall'Alda Marlene, Moretta Rossella, Giagulli Vito Angelo, Bonora Enzo, Moghetti Paolo

Abstract excerpt

CONTEXT/OBJECTIVE: Hyperandrogenism is a common feature of women with polycystic ovary syndrome (PCOS) and is considered a cardinal element for the diagnosis and phenotyping of this condition. Unfortunately, routinely available methods for measuring serum androgens suffer from major limitations. No data are available on the impact of androgen assay quality on the assignment of PCOS women to the different clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgens
Share to Androstenedione

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to False Positive Reactions

Share to Hyperandrogenism

Share to Polycystic Ovary Syndrome

Share to Reference Standards

Share to Risk Assessment

Share to Testosterone

Source

Identifiers

PMID: 26695861
DOI: 10.1210/jc.2015-2807

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome.PMID 26695861Read ↗

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.Semantic proximity Read ↗

Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary SyndromeSemantic proximity Read ↗

Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.Semantic proximity Read ↗

The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.Semantic proximity Read ↗

A comprehensive approach in diagnosing the polycystic ovary syndrome.Semantic proximity Read ↗

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.Semantic proximity Read ↗

Thyroid autoimmunity does not delineate a cardiometabolic or androgenic phenotype in women with polycystic ovary syndrome: a pre-specified cross-sectional analysis.Semantic proximity Read ↗

Thyroid Autoimmunity Does Not Delineate a Cardiometabolic or Androgenic Phenotype in Women With Polycystic Ovary Syndrome: A Pre-Specified Cross-Sectional AnalysisSemantic proximity Read ↗

High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome.Semantic proximity Read ↗

MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes.Semantic proximity Read ↗

Can the source of hyperandrogenism in adolescents with polycystic ovary syndrome predict metabolic phenotype?Semantic proximity Read ↗

Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.